177 related articles for article (PubMed ID: 15372086)
21. The potential of pharmacogenetics in the treatment of epilepsy.
Depondt C
Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenomics: historical perspective and current status.
Kalow W
Methods Mol Biol; 2005; 311():3-15. PubMed ID: 16100395
[TBL] [Abstract][Full Text] [Related]
23. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
Smart A; Martin P
Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenetics in drug development.
McCarthy AD; Kennedy JL; Middleton LT
Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1579-88. PubMed ID: 16096107
[TBL] [Abstract][Full Text] [Related]
25. Applying technologies towards safe and effective medicines.
Roses AD
Biotechniques; 2005 Oct; 39(4):563-4. PubMed ID: 16235568
[No Abstract] [Full Text] [Related]
26. Discordance between availability of pharmacogenetics studies and pharmacogenetics-based prescribing information for the top 200 drugs.
Zineh I; Pebanco GD; Aquilante CL; Gerhard T; Beitelshees AL; Beasley BN; Hartzema AG
Ann Pharmacother; 2006 Apr; 40(4):639-44. PubMed ID: 16595569
[TBL] [Abstract][Full Text] [Related]
27. Pharmacogenetics in neuropsychiatric diseases: epilepsy as a model.
Depondt C
Acta Neurol Belg; 2006 Dec; 106(4):157-67. PubMed ID: 17323833
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenetics of osteoporosis: future perspectives.
Marini F; Brandi ML
Calcif Tissue Int; 2009 May; 84(5):337-47. PubMed ID: 19271099
[TBL] [Abstract][Full Text] [Related]
29. Drug evaluation, drug development and pharmacogenetics: celebrating 30 years of progress.
Li Wan Po A
J Clin Pharm Ther; 2005 Feb; 30(1):1-4. PubMed ID: 15658998
[No Abstract] [Full Text] [Related]
30. Pharmacogenetics: improving drug and dose selection.
Bhathena A; Spear BB
Curr Opin Pharmacol; 2008 Oct; 8(5):639-46. PubMed ID: 18762278
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacogenomics: the quest for individualized therapy].
López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
[TBL] [Abstract][Full Text] [Related]
32. Integration of pharmacogenetics and pharmacogenomics in drug development: implications for regulatory and medical decision making in pediatric diseases.
Piana C; Surh L; Furst-Recktenwald S; Iolascon A; Jacqz-Aigrain EM; Jonker I; Russo R; van Schaik RH; Wessels J; Della Pasqua OE
J Clin Pharmacol; 2012 May; 52(5):704-16. PubMed ID: 21566202
[TBL] [Abstract][Full Text] [Related]
33. Developing paediatric medicines: identifying the needs and recognizing the challenges.
Ernest TB; Elder DP; Martini LG; Roberts M; Ford JL
J Pharm Pharmacol; 2007 Aug; 59(8):1043-55. PubMed ID: 17725846
[TBL] [Abstract][Full Text] [Related]
34. Methodological quality of pharmacogenetic studies: issues of concern.
Jorgensen AL; Williamson PR
Stat Med; 2008 Dec; 27(30):6547-69. PubMed ID: 18837075
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenetics goes genomic.
Goldstein DB; Tate SK; Sisodiya SM
Nat Rev Genet; 2003 Dec; 4(12):937-47. PubMed ID: 14631354
[TBL] [Abstract][Full Text] [Related]
36. Scientific visualization in drug discovery and development.
Albensi BC
Drug News Perspect; 2001 Mar; 14(2):69-74. PubMed ID: 12819797
[TBL] [Abstract][Full Text] [Related]
37. Making better drugs: Decision gates in non-clinical drug development.
Pritchard JF; Jurima-Romet M; Reimer ML; Mortimer E; Rolfe B; Cayen MN
Nat Rev Drug Discov; 2003 Jul; 2(7):542-53. PubMed ID: 12815380
[TBL] [Abstract][Full Text] [Related]
38. Maximizing the value of medicines by including pharmacogenetic research in drug development and surveillance.
Brazell C; Freeman A; Mosteller M
Br J Clin Pharmacol; 2002 Mar; 53(3):224-31. PubMed ID: 11874384
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenetics place in modern medical science and practice.
Roses AD
Life Sci; 2002 Feb; 70(13):1471-80. PubMed ID: 11895098
[TBL] [Abstract][Full Text] [Related]
40. Pipeline pharmacogenetics: a novel approach to integrating pharmaco-genetics into drug development.
Akkari PA; Swanson TW; Crenshaw DG; Grossman I; Sundseth S; Burns DK; Roses AD
Curr Pharm Des; 2009; 15(32):3754-63. PubMed ID: 19925426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
